Shoppers Drug Mart may have yet to receive its medical cannabis license from Health Canada, but it is moving full steam ahead to make sure it has secured multiple Canadian cannabis suppliers to provide its customers with products.
Tag Archives: APH
Aphria Begins to Divest of its Equity Investment in Passive US Assets
LEAMINGTON, Ontario, Feb. 5, 2018 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today announced that it entered into a purchase and sale agreement to sell 26,716,025 shares representing all its shares in Liberty Health Sciences Inc. (“Liberty”) that are not subject to Canadian Securities Exchange (“CSE”) escrow requirements.
Aphria And Liberty Health Sciences Announce Definitive Agreement For Sale Of Aphria’s Investment In Copperstate Farms To Liberty
LEAMINGTON AND TORONTO, Ontario, Feb. 2, 2018 /Weed Wire/ — Aphria Inc. (TSX:APH or OTCQB:APHQF) (“Aphria”) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) (“Liberty”) jointly announce that they have entered into a definitive agreement (the “Agreement”) with respect to the sale (the “Transaction”) of Aphria’s subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) to Liberty for a purchase price of $20 million (“Purchase Price”).
Shoppers Drug Mart Marijuana Closer to Reality With Second Supplier Named
Shoppers Drug Mart marijuana is one step closer to reality after a public Canadian marijuana company announced that it has signed on to be the Canadian pharmacy chain’s second medical marijuana supplier.
Aphria Stock Soars After Announcement of Cannabis Deal With Shoppers Drug Mart
Following market close on Dec. 4, 2017, Aphria Inc. (TSX:APH), an Ontario-based licensed producer of medical cannabis, made headlines when it announced that it had entered into an agreement to be the medical cannabis supplier for Shoppers Drug Mart, a Canadian pharmacy chain.
Marijuana Index Dips 3% in June as Canadian Stocks Continue to Decline
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 3% in June as continued losses in Canada closed out the Index’s second worst performing quarter since its inception in January 2015.
Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%
LEAMINGTON, Ontario, March 27, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF), through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC (“Investors”).
Aphria Continues Success Story With TSX Listing
LEAMINGTON, Ontario, March 21, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.
Aphria Receives Conditional Approval to Graduate to the TSX
LEAMINGTON, Ontario, Feb. 6, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange and list its common shares on the TSX.
Aphria’s Vision to be Reality – Part IV Expansion Project to Increase Greenhouse Growing Space to 1 Million Square Feet
LEAMINGTON, Ontario, Jan. 16, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that its Board approved a $137 million capital project, known internally as Part IV expansion.
Aphria Reports 19% Growth in Quarterly Revenue
LEAMINGTON, Ontario, Jan. 11, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) today reported its second quarter results, for the three months ended November 30, 2016.
Aphria Continues Expansion Strategy
LEAMINGTON, Ontarion, Dec. 14, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement to acquire 200 acres of fully serviced vacant land for $6.24 million located at 521 Mersea Road 8, Leamington, Ontario.
Aphria Inc. Announces $35 Million Bought Deal
LEAMINGTON, Ontario, Nov. 11, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that it has entered into an agreement with Clarus Securities Inc.
Aphria Welcomes Arlene Dickinson to its Board of Directors
LEAMINGTON, Ontario, Oct. 28, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that Arlene Dickinson was elected as a new director at the Company’s annual general meeting held on October 27, 2016.
Aphria Enters Into IP Transfer Agreement in Arizona
LEAMINGTON, Ontario, Oct. 27, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that it has entered into an Intellectual Property transfer agreement with Copperstate Farms, LLC (“Copperstate”).
Aphria Announces Licence Amendment
LEAMINGTON, Ontario, Sept. 26, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced an amendment to is licence by Health Canada, allowing it to grow up to 3,600 kilograms of dried cannabis and to sell up to 2,800 kilograms of dried cannabis, over the next year.
Aphria Finalizes Licensing Deal With Tokyo Smoke
TORONTO, Ontario, Sept. 19, 2016 /Weed Wire/ — Aphria Inc. (“Aphria”) (TSX VENTURE:APH)(OTCQB:APHQF), in connection with its previously announced licensing deal with Tokyo Smoke, a premium cannabis-oriented lifestyle brand, has issued to Tokyo Smoke 38,759 common shares of Aphria and 200,000 common share purchase warrants exercisable for a period of 5 years at an exercise price of $3.14 per warrant.
Aphria to Triple Its Production Space as it Starts Part III Expansion
LEAMINGTON, Ontario, Sept.16,2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce that its Board of Directors approved a fully funded $24.5 million capital project as the first phase of its Part III expansion.
Aphria Partners With Leading International Consumer Lifestyle Brand Tokyo Smoke
TORONTO, Sept. 7, 2016 /Weed Wire/ — Today Aphria Inc. (“Aphria”) (TSX VENTURE:APH) (OTCQB:APHQF), one of Canada’s leading licensed producers of medical cannabis, announced a groundbreaking licensing deal with Tokyo Smoke, a premium cannabis-oriented lifestyle brand.
Aphria Accelerates Expansion Strategy
LEAMINGTON, Ontario, Aug. 19, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement with DiNiro Farms Inc. (“DiNiro”) to acquire 11 acres of additional property adjacent to its existing campus for a $2.1 million cash payment.
Aphria Inc. Announces $25 Million Bought Deal
LEAMINGTON, Ontario, July 28, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that it has entered into an agreement with Clarus Securities Inc.
Aphria Announces Project to More Than Double Growing Capacity
LEAMINGTON, Ontario, June 2, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) is pleased to announce that its board approved a fully funded $10 million capital project.
ESEV Genetics Scores With Canada’s Aphria to Create Strongest Strains
LEAMINGTON, Ontario, Feb. 1, 2016 /Weed Wire/ — Aphria Inc (TSX VENTURE:APH), one of Canada’s leading large scale producers of medical-grade cannabis, partners with pioneering ESEV Genetics to develop and bring to market the highest quality strains of cannabis available to treat a range of medical conditions.
Understanding Canadian Public Markets
While investment in cannabis industries is limited in the U.S. by federal law, Canadian companies and investors don’t face these same restrictions.
Cannabis in Canada: A Data Snapshot
The evolution of the cannabis market in Canada continues to be a crucial case study. There is a lot we can learn about how business models are taking shape and the headwinds being faced in the legalized medical environment that the Canadian MMPR provides.
Monday Monitor and Adjust
Energy continues to spiral downward, putting pressure on U.S. stocks for the day. Additionally, emerging market currencies continue to weaken against the dollar, to the lowest point in a decade. Putin is crying in his borsch. The S&P 500 posted a decline of 0.69% to 2,061.